First Block Launches Solana STO for U.S. Medical Device Firm Onpharma
Layer 1Adoption
Neutral

First Block Launches Solana STO for U.S. Medical Device Firm Onpharma

First Block, Onpharma, and Crito Capital announced the first security token offering on Solana for a real operating company, tokenizing equity in a U.S. dental medical device business. The offering marks the first time a functioning company with recurring revenue has raised capital via Solana-based tokenized securities.

Sep 28, 2026, 01:04 AM1 min read

Written by CoinArticle’s AI Newsroom · from 2 cited sources. How we work

First Solana STO for Operating Company

First Block, a digital securities infrastructure provider, announced Tuesday the launch of what it claims is the first security token offering on Solana tied to an operating U.S. business. The offering tokenizes equity in Onpharma Company, a Delaware-incorporated medical device maker focused on dental technology. Crito Capital, a UK-based investment firm, is backing the offering as a co-sponsor.

Onpharma's core assets include recurring-revenue dental device technology with what the offering materials describe as high gross margins and a significant addressable market. Unlike prior token launches tied to speculative projects or pre-revenue ventures, this STO represents equity in a company already generating operational cash flow.

Infrastructure and Architecture

First Block deployed what it calls next-generation digital securities architecture to facilitate the offering, handling both the issuance mechanics and custody infrastructure on Solana. The move tests whether Solana's transaction throughput and settlement speed can serve as a viable rail for regulated security token offerings, a use case distinct from speculative trading or DeFi.

The offering does not appear to have commenced a public fundraising phase as of the announcement date; the press release functions as notification of the structure rather than disclosure of capital raised or valuation.

Why It Matters

For Traders

Solana-based security tokens remain illiquid and lightly traded; secondary market depth for this STO is unknown and likely minimal near term.

For Investors

Successful STO execution on Solana demonstrates regulatory feasibility for tokenized equity, a structural shift if replicated by larger operating companies.

For Builders

This use case validates Solana's settlement layer for regulated securities infrastructure, potentially attracting fintech and compliance-layer protocols to the ecosystem.

This article is for information only and is not financial advice. Read the full disclaimer.

Live prices:Solana

Related Articles

Latest News